Local Radiation Therapy for Bladder Cancer Not Suitable for Surgery
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether focused radiation therapy directed at the bladder can help patients with muscle-invasive bladder cancer who are not candidates for surgical removal or have chosen not to have surgery. The goal is to see if this approach can control the cancer and improve quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with muscle-invasive urothelial bladder cancer (a common type of bladder cancer that has grown into the muscle layer)
- Your medical team has determined you are not a good candidate for curative treatment (surgery to remove the bladder), or you have chosen not to have this surgery
- You are at least 18 years old
- You have not had previous radiation therapy to the pelvis (lower abdomen), or any previous radiation does not significantly overlap with the treatment area
- You do not have cancer that has spread to distant organs (liver, lungs, bones) or multiple enlarged lymph nodes
- You are not currently scheduled to receive chemotherapy at the time you would start this trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how well radiation therapy works as the main treatment for bladder cancer. It may help people who haven't had their bladder removed before.
This trial tests a new online adaptive radiotherapy technique for bladder cancer that adjusts the radiation plan daily based on changes in the bladder. It aims to improve treatment accuracy and reduce side effects.
This trial tests whether radiation therapy can help people whose bladder cancer (specifically carcinoma in situ) did not get better with BCG treatment and who are not having their bladder removed. It aims to offer a less invasive option for controlling the cancer.
This trial tests radiotherapy (high-energy X-rays) for a specific type of early-stage bladder cancer (CIS) that hasn't gone away after BCG treatment. It's for people who can't or choose not to have bladder removal surgery.
This trial tests whether giving focused radiation (SBRT) to a few remaining metastatic spots can stop bladder cancer from progressing after initial chemotherapy or immunotherapy has worked. It may help patients who still have up to three remaining distant lesions but are not getting worse.
This trial compares radiotherapy with a radiosensitizer to BCG therapy for people with high-risk non-muscle invasive bladder cancer. The goal is to see which treatment better controls the cancer and helps patients avoid bladder removal.
Hear when a new Bladder Cancer (BC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.